| __timestamp | Jazz Pharmaceuticals plc | Taro Pharmaceutical Industries Ltd. |
|---|---|---|
| Wednesday, January 1, 2014 | 406114000 | 91733000 |
| Thursday, January 1, 2015 | 449119000 | 87644000 |
| Friday, January 1, 2016 | 502892000 | 92365000 |
| Sunday, January 1, 2017 | 544156000 | 85656000 |
| Monday, January 1, 2018 | 683530000 | 88196000 |
| Tuesday, January 1, 2019 | 736942000 | 89971000 |
| Wednesday, January 1, 2020 | 854233000 | 93413000 |
| Friday, January 1, 2021 | 1451683000 | 91355000 |
| Saturday, January 1, 2022 | 1416967000 | 113676000 |
| Sunday, January 1, 2023 | 1343105000 | 198366000 |
| Monday, January 1, 2024 | 218935000 |
Unlocking the unknown
In the competitive world of pharmaceuticals, managing Selling, General, and Administrative (SG&A) expenses is crucial for profitability. Jazz Pharmaceuticals plc and Taro Pharmaceutical Industries Ltd. have taken different paths in this regard. From 2014 to 2023, Jazz Pharmaceuticals saw a staggering 230% increase in SG&A expenses, peaking in 2021. In contrast, Taro Pharmaceutical Industries Ltd. maintained a more stable trajectory, with expenses growing by approximately 140% over the same period.
Jazz Pharmaceuticals' expenses surged notably in 2021, reaching their highest point, while Taro's costs remained relatively consistent, with a slight uptick in 2023. This suggests that Taro has been more effective in controlling its SG&A costs, despite Jazz's larger scale. The data highlights the importance of strategic cost management in sustaining competitive advantage in the pharmaceutical industry.
Who Optimizes SG&A Costs Better? Alnylam Pharmaceuticals, Inc. or Jazz Pharmaceuticals plc
Breaking Down SG&A Expenses: Dr. Reddy's Laboratories Limited vs Jazz Pharmaceuticals plc
Operational Costs Compared: SG&A Analysis of Dr. Reddy's Laboratories Limited and Taro Pharmaceutical Industries Ltd.
BioMarin Pharmaceutical Inc. and Jazz Pharmaceuticals plc: SG&A Spending Patterns Compared
Breaking Down SG&A Expenses: Jazz Pharmaceuticals plc vs Alpine Immune Sciences, Inc.
Breaking Down SG&A Expenses: Jazz Pharmaceuticals plc vs ADMA Biologics, Inc.
Comparing SG&A Expenses: Jazz Pharmaceuticals plc vs Bausch Health Companies Inc. Trends and Insights
Jazz Pharmaceuticals plc vs Xencor, Inc.: SG&A Expense Trends
Blueprint Medicines Corporation vs Taro Pharmaceutical Industries Ltd.: SG&A Expense Trends
Selling, General, and Administrative Costs: Ultragenyx Pharmaceutical Inc. vs Taro Pharmaceutical Industries Ltd.
Comparing SG&A Expenses: Veracyte, Inc. vs Taro Pharmaceutical Industries Ltd. Trends and Insights
Who Optimizes SG&A Costs Better? Amphastar Pharmaceuticals, Inc. or Taro Pharmaceutical Industries Ltd.